Published in Blood Weekly, April 22nd, 1996
New compounds with high levels of activity against the parasites and that also are safe are needed, noted Egler Chiari, Federal University of Minas Gerais, Belo Horizonte, Brazil, and colleagues ("Potential Use of WR6026 as Prophylaxis against Transfusion-Transmitted American Trypanosomiasis," Antimicrobial Agents & Chemotherapy, March 1996;40(3):613-615).
Chiari et al., along with researchers from Palo Alto Medical Foundation, Palo Alto, California, indicated that they are actively searching for such new compounds. They said they have been exploring...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.